But where the business inducements enter unprecedented terrain is health and safety regulation. Próspera won’t impose rules so much as curate prix fixe and à la carte menus of rules.
Delgado has held talks with a controversial gene-therapy startup, Minicircle, to open a clinic in Próspera. It will be funded by a “network of crypto investors,” according to its CEO, Machiavelli Davis. Davis runs in biohacking circles, a set best known for self-administering untested gene therapies.
That's...actually kinda cool.
I believe they did it specifically for the purpose of making many of the patentable stuff that would make gene therapy require the parents to develop unpatentable. As in, all the base parts of it needed to do any sort of gene therapy would be unpatentable, but companies could still patent specific implementations of it.